BPC-157 5MG

BPC-157 (Body Protection Compound 157) is a synthetic 15-amino acid peptide derived from a protein found in gastric juice that has gained significant attention for its regenerative and healing properties across multiple tissue types. 3 7 A 5 mg preparation represents a concentrated form typically reconstituted for injection or used in oral formulations, though dosing is individualized based on administration route and therapeutic goal.

Primary Benefits of BPC-157

Accelerated Tissue and Wound Healing

BPC-157 is most renowned for its ability to expedite healing across diverse tissues including muscles, tendons, ligaments, bones, and skin. 3 6 It works by stimulating collagen synthesis, enhancing tissue regeneration, and promoting the formation of new blood vessels through modulation of vascular endothelial growth factor (VEGF) expression. 3 9 This makes it particularly valuable for athletes recovering from sports injuries, post-surgical healing, and chronic musculoskeletal conditions like tendonitis. 3 6

Anti-Inflammatory and Pain Relief Effects

BPC-157 modulates inflammatory pathways by reducing cytokine production and inflammatory responses, thereby alleviating pain and swelling associated with conditions such as arthritis, inflammatory bowel disease, and chronic pain from nerve damage. 3 9 The peptide enhances blood flow through angiogenesis—the formation of new blood vessels—which supplies nutrients and oxygen to injured areas while removing inflammatory byproducts. 9

Gastrointestinal and Gut Health Improvement

BPC-157 shows remarkable efficacy for gut-related conditions, including healing gastric ulcers, repairing damaged intestinal lining, and improving overall gastrointestinal function. 3 6 It remains active in gastric environments and has demonstrated consistent mucosal protection across ulcer models, making it particularly beneficial for conditions like leaky gut syndrome, ulcerative colitis, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). 5 6

Joint, Cartilage, and Bone Health

The peptide promotes healing of damaged joints, cartilage, and bones, with potential applications in treating osteoarthritis, rheumatoid arthritis, and osteoporosis. 3 It reduces muscle scarring following injury, which is critical since scarring impairs muscle function and mobility. 9

Muscle Preservation and Strength Enhancement

BPC-157 combats muscle atrophy, particularly in cases of chronic disease or severe injuries, helping preserve tissue and muscle functionality while amplifying muscle strength and endurance. 7 9 This dual effect—promoting tissue repair while preventing wasting—makes it valuable for recovery optimization.

Neuroprotection and Nerve Injury Recovery

The peptide exhibits neuroprotective properties, particularly benefiting injuries involving nerve damage through its interactions with growth factors like fibroblast growth factor (FGF) and the nitric oxide system, which play major roles in neuronal repair and immune modulation. 9

Administration Routes and Dosage

BPC-157 can be administered through multiple routes, each with distinct advantages: 1 2 4 6

Injectable Administration (Subcutaneous or Intramuscular)

• Typical dosing: 250–500 mcg once or twice daily, with some protocols ranging up to 750–1,000 mcg daily depending on condition severity
• Body-weight based dosing: 2.5–3.75 micrograms per kilogram of body weight, twice daily
• Cycle duration: 2–6 weeks depending on injury type, with 4–8 week breaks between cycles recommended
• Delivery method: SubQ injections near the injury site provide superior bioavailability and localized healing; intramuscular injections are less common but used for deep tissue or joint injuries
• A 5 mg vial reconstituted typically provides multiple doses when diluted appropriately

Oral or Sublingual Administration

• Typical dosing: 250–500 mcg taken 1–2 times daily on an empty stomach
• Best use case: Particularly effective for gastrointestinal conditions and systemic inflammation, though bioavailability is lower than injectable forms
• Cycle duration: 2–6 weeks, adjustable based on gastrointestinal or systemic effects
• Despite potential digestive tract degradation, oral BPC-157 demonstrates effectiveness for gut healing and is more convenient than injections